Prostatic Cancer Versus Androgen Deficiency
Not Applicable
Completed
- Conditions
- Cancer of Prostate
- Interventions
- Other: Blood sample
- Registration Number
- NCT02235142
- Lead Sponsor
- Hopital Foch
- Brief Summary
Open study to make a comparison between hypogonadism and euogonadism patients regarding the severity of prostate cancer. The purpose of this study is to determine the importance of the relationship between the hormonal status and the type of the tumor at the time of surgical intervention as well as follow up of the patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 1614
Inclusion Criteria
- Male patients over than 18 years of age, with localized, stage I or II prostate cancer, not receiving local treatment (radiation, phototherapy, thermotherapy,...) or hormonal therapy, showing indication of radical prostatectomy.
Read More
Exclusion Criteria
- Absence of radical prostatectomy indication
- Patient received local or hormonal therapy prior to surgery
- Patients already enrolled in other clinical study incompatible with the study
- Patients on a treatment which can affect hormonal level (Prednisone, Ketoconazole, Abiraterone, Finasteride, Dutasteride)
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Localised prostat cancer and androgen deficiency Blood sample -
- Primary Outcome Measures
Name Time Method Testosteron Serum level The day prior to surgery Gleason score 5 years
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (8)
CHU Fort de France
馃嚥馃嚩Fort-de-France, Martinique
H么pital Foch
馃嚝馃嚪Suresnes, Ile De France, France
H么pitaux Civils de Colmar
馃嚝馃嚪Colmar, France
Clinique Saint Augustin
馃嚝馃嚪Bordeaux, France
H么pital Henri Mondor
馃嚝馃嚪Cr茅teil, France
La Piti茅-Salp锚tri猫re (AP-HP)
馃嚝馃嚪Paris, France
CHU Pointe 脿 Pitre
馃嚞馃嚨Pointe-脿-Pitre, Guadeloupe
Institut Mutualiste Montsouris
馃嚝馃嚪Paris, France